Litian Zhang
Lanzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The expression and significance of CXCL13 and CXCR5 in the tumor microenvironment of primary central nervous system diffuse large B-cell lymphoma.
Journal: Free radical biology & medicine
Published: July 27, 2025
Tumor microenvironment in primary central nervous system lymphoma (PCNSL).
Journal: Cancer biology & therapy
Published: November 18, 2024
CD36: a promising therapeutic target in hematologic tumors.
Journal: Leukemia & lymphoma
Published: July 10, 2024
Recent advances in CD5+ diffuse large B-cell lymphoma.
Journal: Annals of hematology
Published: January 31, 2024
The prognostic value of CD8+ CTLs, CD163+ TAMs, and PDL1 expression in the tumor microenvironment of primary central nervous system lymphoma.
Journal: Leukemia & lymphoma
Published: January 10, 2024
CD39 (ENTPD1) in tumors: a potential therapeutic target and prognostic biomarker.
Journal: Biomarkers in medicine
Published: September 15, 2023
Role and application of chemokine CXCL13 in central nervous system lymphoma.
Journal: Annals of hematology
Published: September 12, 2023
Frequent Gene Mutations and Their Possible Roles in the Pathogenesis, Treatment and Prognosis of Primary Central Nervous System Lymphoma.
Journal: World neurosurgery
Published: November 10, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026